Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-16

Clinical Trial Update: Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer [Phase 1]

View source ↗

Summary

This document reports a completed Phase I clinical trial from The Netherlands Cancer Institute evaluating carboplatin-olaparib in combination followed by olapar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Olaparib (Olaparib)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED